a
a
Weather:
No weather information available
HomeHealthNewronika Receives CE Mark Approval for AlphaDBS, Advancing Adaptive Deep Brain Stimulation for Parkinson’s Disease

Newronika Receives CE Mark Approval for AlphaDBS, Advancing Adaptive Deep Brain Stimulation for Parkinson’s Disease

MILAN, March 24, 2025 /PRNewswire/ — Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has received CE Mark approval for its AlphaDBS device, a next-generation closed-loop DBS system that dynamically adjusts stimulation…

No comments

Sorry, the comment form is closed at this time.

Translate »